Virtu Financial LLC Repligen Corp Transaction History

Virtu Financial LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	BUY	$170.78 - $208.42 $59,773 - $72,947	350 Added 29.29%	1,545 $284,000
Q4 2023 Feb 26, 2024	SELL	$114.17 - $185.35 $210,529 - $341,785	-1,844 Reduced 60.68%	1,195 $215,000
Q3 2023 Nov 14, 2023	SELL	$138.78 - $176.51 $351,807 - $447,452	-2,535 Reduced 45.48%	3,039 $483,000
Q2 2023 Jul 27, 2023	BUY	$138.42 - $180.31 $109,905 - $143,166	794 Added 16.61%	5,574 $788,000
Q1 2023 May 01, 2023	BUY	$154.26 - $198.1 $737,362 - $946,918	4,780 New	4,780 $805,000
Q2 2021 Sep 17, 2021	SELL	$165.87 - $220.95 $389,794 - $519,232	-2,350 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$180.37 - $226.26 $423,869 - $531,711	2,350 New	2,350 $457,000
Q4 2019 Feb 04, 2020	SELL	$73.84 - $93.08 $289,157 - $364,501	-3,916 Closed	0 $0
Q3 2019 Nov 20, 2019	BUY	$76.65 - $95.51 $300,161 - $374,017	3,916 New	3,916 $300,000
Q1 2019 Apr 12, 2019	SELL	$49.45 - $62.8 $329,139 - $417,996	-6,656 Closed	0 $0
Q4 2018 Jan 16, 2019	BUY	$48.26 - $68.88 $321,218 - $458,465	6,656 New	6,656 $351,000
Q2 2018 Jul 30, 2018	SELL	$35.26 - $47.04 $223,372 - $297,998	-6,335 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$35.26 - $47.04 $223,372 - $297,998	6,335 New	6,335 $298,000

495

53.9M

420K

85.3K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.1B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.